By G HossainPosted on May 4, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Candid Therapeutics follows closely behind Neurona Therapeutics, which UCB acquired in mid-April in a potential $1.15 billion deal. UCB captures Candid in $2.2B autoimmune deal as pharma’s M&A train chugs along Post navigation Obesity ends oncology’s long reign as top contributor to biopharma pipeline valuePCI adds US sterile fill/finish capabilities through $1B global expansion drive